Authors’ response: Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: More data on asymptomatic SARS-CoV-2 infection

Letter Open Access

Like 0

Authors’ response: Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: More data on asymptomatic SARS-CoV-2 infection
Thomas Harder¹ , Judith Koch¹ , Sabine Vygen-Bonnet¹ , Wiebe Külper-Schiek¹ , Antonia Pilic¹ , Sarah Reda¹ , Stefan Scholz¹ , Ole Wichmann¹
View Affiliations Hide Affiliations

Affiliations: ¹ Robert Koch Institute, Berlin, Germany

Correspondence:
Thomas Harder
hardert rki.de
View Citation Hide Citation

Citation style for this article: Harder Thomas, Koch Judith, Vygen-Bonnet Sabine, Külper-Schiek Wiebe, Pilic Antonia, Reda Sarah, Scholz Stefan, Wichmann Ole. Authors’ response: Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: More data on asymptomatic SARS-CoV-2 infection. Euro Surveill. 2021;26(35):pii=2100832. https://doi.org/10.2807/1560-7917.ES.2021.26.35.2100832 Received: 30 Aug 2021; Accepted: 01 Sept 2021

There is no abstract available.

Article metrics loading...

/content/10.2807/1560-7917.ES.2021.26.35.2100832

2021-09-02

2024-04-25

http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2021.26.35.2100832

Full text loading...

/deliver/fulltext/eurosurveillance/26/35/eurosurv-26-35-5.html?itemId=/content/10.2807/1560-7917.ES.2021.26.35.2100832&mimeType=html&fmt=ahah

References

Harder T, Koch J, Vygen-Bonnet S, Külper-Schiek W, Pilic A, Reda S, et al. Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: interim results of a living systematic review, 1 January to 14 May 2021. Euro Surveill. 2021;26(28):2100563. https://doi.org/10.2807/1560-7917.ES.2021.26.28.2100563 PMID: 34269175
Emary KRW, Golubchik T, Aley PK, Ariani CV, Angus B, Bibi S, et al. Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial. Lancet. 2021;397(10282):1351-62. https://doi.org/10.1016/S0140-6736(21)00628-0 PMID: 33798499
Dagan N, Barda N, Kepten E, Miron O, Perchik S, Katz MA, et al. BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting. N Engl J Med. 2021;384(15):1412-23. https://doi.org/10.1016/S0140-6736(21)00628-0 PMID: 33798499

Submit comment

Comment moderation successfully completed